Has James Falk, MD received payments from drug or device companies?

Yes. Drug and device makers reported $207 in general payments to James Falk, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Falk, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Falk, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Falk, MD

Emergency Medicine · Westerville, OHNPI 1124382254

Payments from drug & device makers

$207in general payments, 2019–2025

Across 12 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$52
Portola Pharmaceuticals, LLC$33
E.r. Squibb & Sons, L.L.C.$29
Abbott$23
CSL Behring$20
Gilead$19
plus $31 from 2 others

What the payments were for

Food & beverage$18790%
Education$2010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	3	$52
Portola Pharmaceuticals, LLC	2	$33
E.r. Squibb & Sons, L.L.C.	2	$29
Abbott	1	$23
CSL Behring	1	$20
Gilead	1	$19
Pfizer	1	$19
AstraZeneca	1	$12

How this compares

$207 in reported general payments places this provider in the 80th percentile of 2,431 emergency medicine providers in Ohio.

See all emergency medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$72,393

Medicare patients

449

Services billed

477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	83	$1,079
Cephalexin	35	$176
Sucralfate	11	$148
Promethazine Hcl	11	$105
Famotidine	22	$86
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$71
Meclizine Hcl	13	$66
Prednisone	25	$58
Amoxicillin	12	$52
Dicyclomine Hcl	13	$50
Azithromycin	13	$43
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	16	$39
Cyclobenzaprine Hcl	22	$37
Metoclopramide Hcl	19	$27

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Westerville

Mary Beth ManningBedford$8.6M
Justin ArambasickDayton$2.3M
James NeuenschwanderMount Vernon$973K
Gregory FermannCincinnati$958K
Thomas NaumoffBeachwood$746K
Paul HogyaSouth Lebanon$468K
Joan RothenbergStrongsville$412K
Sharon MaceCleveland$385K
Henry WangColumbus$331K
Kyle WalshCincinnati$224K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →